Hiranyagarbha Ayurved Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -75.00%
- Profit Growth 91.27%
- Ebitda 91.27%
- Net Worth -13.64%
- Total Assets -26.50%
About Hiranyagarbha Ayurved Pharmacy
Hiranyagarbha Ayurved Pharmacy Private Limited (HAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 May 2018 (Six years and nine months 23 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saroj Pachore, Namdev Shripati, and Saurabh Ghavte serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110PN2018PTC176427
- Company No.
176427
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Hiranyagarbha Ayurved Pharmacy?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Ghavte  | Director | 07-Aug-2023 | Current |
| Saroj Pachore | Director | 04-May-2018 | Current |
| Namdev Shripati | Director | 04-May-2018 | Current |
Financial Performance of Hiranyagarbha Ayurved Pharmacy.
Hiranyagarbha Ayurved Pharmacy Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 75% decrease. The company also saw a substantial improvement in profitability, with a 91.27% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hiranyagarbha Ayurved Pharmacy?
Unlock access to Hiranyagarbha Ayurved Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Susan Biopharma Private LimitedSaurabh Ghavte is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hiranyagarbha Ayurved Pharmacy?
Unlock and access historical data on people associated with Hiranyagarbha Ayurved Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hiranyagarbha Ayurved Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hiranyagarbha Ayurved Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.